HIF2α is increased in lung vascular ECs (LVECs) of IPAH patients which was associated with downregulation of HIF2α degrading enzyme prolyl hydroxylase domain protein 2 (PHD2). The gene discussed is EPAS1; the disease is idiopathic pulmonary arterial hypertension.